Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes.
Bebernitz GR, Beaulieu V, Dale BA, Deacon R, Duttaroy A, Gao J, Grondine MS, Gupta RC, Kakmak M, Kavana M, Kirman LC, Liang J, Maniara WM, Munshi S, Nadkarni SS, Schuster HF, Stams T, St Denny I, Taslimi PM, Vash B, Caplan SL.
Bebernitz GR, et al. Among authors: gao j.
J Med Chem. 2009 Oct 8;52(19):6142-52. doi: 10.1021/jm900839k.
J Med Chem. 2009.
PMID: 19746978